Poly Medicure Ltd (POLYMED)
₹1,449.50
Mkt cap
₹14,818 Cr
P/E ratio
46.30
P/B
4.74
Div yield
0.24%
ROE
9.02%
ROCE
12.50%
EPS (TTM)
₹31.31
Book value
₹306
52W range
1,182–2,094
Sector
Healthcare
Price history
Previous close
Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices. [1]
NSE POLYMEDBSE 531768
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−30.79% from high₹1,450
₹1,182+22.63% from low₹2,094
Current
₹1,449.50
Prev close
₹1,461.90
Day
−0.85%
Price performance
1D
−0.34%
1W
+0.90%
1M
−11.41%
3M
−12.61%
6M
−4.01%
1Y
−24.24%
YTD
−18.09%
Financials
Revenue, profit & margin
P/E ratio
46.3×
POLYMED is 35% above the sector median of 34.4×
POLYMED46.3×
Sector median34.4×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 321 | 337 | 340 | 378 | 385 | 420 | 424 | 441 | 403 | 444 | 494 | 535 | 525 | |
| Expenses | 234 | 253 | 249 | 282 | 281 | 305 | 310 | 321 | 298 | 329 | 382 | 424 | 400 | |
| Operating Profit | 87 | 84 | 90 | 96 | 104 | 115 | 114 | 119 | 106 | 115 | 111 | 110 | 125 | |
| OPM % | 27% | 25% | 27% | 26% | 27% | 27% | 27% | 27% | 26% | 26% | 23% | 21% | 24% | |
| Other Income | 14 | 15 | 17 | 15 | 17 | 27 | 24 | 27 | 43 | 35 | 21 | 19 | 35 | |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 6 | 6 | 6 | |
| Depreciation | 16 | 16 | 16 | 16 | 20 | 21 | 21 | 21 | 23 | 25 | 29 | 38 | 36 | |
| Profit before tax | 83 | 81 | 88 | 92 | 98 | 118 | 113 | 123 | 123 | 122 | 98 | 85 | 117 | |
| Tax % | 24% | 23% | 26% | 26% | 25% | 26% | 25% | 25% | 24% | 25% | 27% | 24% | 27% | |
| Net Profit | 63 | 62 | 65 | 68 | 74 | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 | |
| EPS in Rs | 6.54 | 6.48 | 6.78 | 7.12 | 7.71 | 8.63 | 8.41 | 9.06 | 9.19 | 9.06 | 7.00 | 6.54 | 8.49 | |
| Raw PDF |
Earnings
Results dates & reactionsNext results
5 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.08% · closed higher next day 28 of last 56
| Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 4 Nov '23◦ | 31 Jan '24◦ | 17 May '24◦ | 22 Jul '24◦ | 28 Oct '24◦ | 3 Feb '25◦ | 7 May '25 | 8 Aug '25 | 8 Nov '25◦ | 5 Feb '26 | 25 May '26 | 7 Aug '26 |
| Earnings day | −6.16% | +1.62% | +1.08% | −0.46% | −2.10% | +5.81% | +1.94% | −0.45% | −1.66% | −0.97% | −3.19% | +4.64% |
| +1 day | −3.60% | +4.36% | +6.28% | −0.78% | +6.31% | +8.91% | −3.83% | +1.96% | +8.96% | −8.42% | −9.91% | +10.04% |
| +5 days | −2.88% | +7.37% | +10.14% | −3.88% | +8.17% | −1.29% | −15.44% | −1.89% | +2.63% | −13.23% | −17.32% | +2.35% |
| +15 days | +3.54% | +9.60% | +12.97% | −5.89% | −1.62% | −4.45% | −15.31% | +7.30% | +2.02% | −17.04% | −5.09% | +3.88% |
| +30 days | +1.00% | −1.63% | +19.82% | +22.42% | +8.24% | −1.79% | −23.22% | +0.86% | −4.91% | −18.21% | +1.01% | +0.31% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202662.41%Promoter
Promoters62.41%0.01
FIIs5.36%0.20
DIIs15.90%0.18
Public16.33%0.39
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnosti | ₹1,302.60 | 69.14 | 15,011 | 0.00% | 57 | +522.30% | 399 | +318.99% | 17.96% |
| Poly Medicure | ₹1,461.90 | 46.30 | 14,818 | 0.24% | 85 | −7.57% | 525 | +30.30% | 12.50% |
| Sahajanand Medi | ₹476.55 | 73.91 | 4,844 | 0.00% | 15 | — | 352 | — | 11.35% |
| Fischer Medical | ₹25.93 | 74.01 | 1,812 | 0.19% | 4 | −22.02% | 82 | +249.49% | 11.45% |
| Tarsons Products | ₹303.95 | 136.59 | 1,617 | 0.00% | −1 | −180.90% | 110 | +20.67% | 4.59% |
| Q-Line Biotech | ₹539.05 | 22.20 | 1,258 | 0.00% | 34 | +147.29% | 198 | −8.59% | 22.45% |
| Laxmi Dental | ₹177.37 | 28.06 | 976 | 0.00% | 10 | +22.77% | 75 | +13.87% | 15.05% |
| Median: 18 Co. | ₹303.42 | 34.42 | 683 | 0.00% | 4 | +14.18% | 78 | +22.98% | 15.20% |
Filings
Annual reports15
Concall transcripts50
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026PPTMay 2026TranscriptMar 2026PPTMar 2026RECMar 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptOct 2025PPTOct 2025TranscriptSep 2025PPTSep 2025TranscriptSep 2025PPTSep 2025RECSep 2025PPTAug 2025TranscriptMay 2025PPTMay 2025
Credit ratings6
Announcements5
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 05Th November, 2026 29 Oct - Board meeting on 5 November 2026 to approve Q2 and half-year results; trading window closed till 7 November.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Oct - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018Closure of Trading Window 28 SepIntimation For The Schedule Of Investors/Analysts Call/Meet. 24 Sep - Poly Medicure to hold one-on-one investor meeting with Avendus Spark on 30 September 2026.Intimation For The Schedule Of Investors/Analysts Call/Meet. 23 Sep - Poly Medicure will hold a virtual one-on-one investor meeting with Dam Capital on 25 September 2026, 11:00 AM.